Peter Bolli
About
In The Last Decade
Peter Bolli
132 papers receiving 3.7k citations
Hit Papers
Peers
Comparison fields: 5 of 143
- Cardiology and Cardiovascular Medicine 2.3k
- Endocrinology, Diabetes and Metabolism 656
- Molecular Biology 635
- Physiology 501
- Surgery 406
Countries citing papers authored by Peter Bolli
This map shows the geographic impact of Peter Bolli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Bolli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Bolli more than expected).
Fields of papers citing papers by Peter Bolli
This network shows the impact of papers produced by Peter Bolli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Bolli. The network helps show where Peter Bolli may publish in the future.
Co-authorship network of co-authors of Peter Bolli
This figure shows the co-authorship network connecting the top 25 collaborators of Peter Bolli. A scholar is included among the top collaborators of Peter Bolli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter Bolli. Peter Bolli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 24 | |
| 2 | 58 | |
| 3 | 18 | |
| 4 | 40 | |
| 5 | 9 | |
| 6 | The 2000 Canadian recommendations for the management of hypertension: part two--diagnosis and assessment of people with high blood pressure. | 11 |
| 7 | 1999 Canadian recommendations for the management of hypertension | 81 |
| 8 | 6. Recommendations on potassium, magnesium and calcium | 18 |
| 9 | 17 | |
| 10 | 9 | |
| 11 | 34 | |
| 12 | 17 | |
| 13 | 4 | |
| 14 | 1 | |
| 15 | 3 | |
| 16 | 7 | |
| 17 | Antihypertensive efficacy of a new long acting hydralazine like vasodilator, ISF 2469 in combination with a betablocker and a diuretic. | 10 |
| 18 | The Milton survey: Part 1, General methods, height, weight and 24-hour excretion of sodium, potassium, calcium, magnesium and creatinine. | 33 |
| 19 | Treatment of hypertension with labetalol. | 8 |
| 20 | A preliminary clinical trial of Prazosin: a new oral antihypertensive agent. | 15 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.